Market Cap 1.65B
Revenue (ttm) 79.95M
Net Income (ttm) -4.60M
EPS (ttm) N/A
PE Ratio 154.82
Forward PE 52.29
Profit Margin -5.75%
Debt to Equity Ratio 0.60
Volume 323,500
Avg Vol 577,966
Day's Range N/A - N/A
Shares Out 28.58M
Stochastic %K 14%
Beta 0.90
Analysts Strong Sell
Price Target $64.10

Company Profile

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyros...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 847 787 7361
Address:
21925 W. Field Parkway, Suite 235, Deer Park, United States
AllenNash21
AllenNash21 Sep. 11 at 4:29 AM
$ETON personal price target of $75 by year end
0 · Reply
Dusan8989
Dusan8989 Sep. 9 at 2:55 PM
$ETON beast on red day
1 · Reply
badgermobile
badgermobile Sep. 9 at 1:10 AM
$ETON they just keep delivering with rev growth and margins acceleration. I think they will hit $100 early next year with continued success
0 · Reply
AllenNash21
AllenNash21 Sep. 8 at 9:56 PM
$ETON serves as a model for other Bios to emulate.
0 · Reply
SpyVsSpy2
SpyVsSpy2 Sep. 2 at 7:42 PM
0 · Reply
kshonstocks
kshonstocks Sep. 2 at 1:38 PM
$ETON back over 9 dma
1 · Reply
Merlintrader
Merlintrader Sep. 2 at 12:44 AM
Eton Pharmaceuticals ($ETON) Stock Hub 2026: Q2 growth, 145M guidance and the valuation test Free Biotech Catalyst Calendar on Merlintrader. https://www.merlintrader.com/eton-pharmaceuticals-stock-hub/
0 · Reply
parcha
parcha Aug. 27 at 12:26 AM
$ETON Eton Pharmaceuticals : “It’s a biotech that’s been a winner. I like to take a little bit off of the biotech winner and then let the rest run.” https://www.cnbc.com/2026/08/26/cramers-lightning-round-buy-qxo.html
0 · Reply
oaksapollo
oaksapollo Aug. 26 at 4:28 PM
$ETON It's interesting, if you look at the bids on calls in Oct, Nov, they're pretty insane. For example, the bid on a November $90 call is $0.90. Pretty bullish, but there is no volume.
0 · Reply
CARTE_BLANCHE_DEVEREAUX
CARTE_BLANCHE_DEVEREAUX Aug. 26 at 4:11 PM
$ETON $SLS $PYPD Closed half my position here. Moved gains from here to $DRTS
3 · Reply
Latest News on ETON
Eton Pharmaceuticals Earnings Call Transcript: Q2 2026

Aug 13, 2026, 4:30 PM EDT - 4 weeks ago

Eton Pharmaceuticals Earnings Call Transcript: Q2 2026


Eton Pharmaceuticals Earnings release: Q2 2026

Aug 13, 2026, 4:30 PM EDT - 4 weeks ago

Eton Pharmaceuticals Earnings release: Q2 2026


Eton Pharmaceuticals Quarterly report: Q2 2026

Aug 13, 2026, 4:30 PM EDT - 4 weeks ago

Eton Pharmaceuticals Quarterly report: Q2 2026


Eton reports results from new formulation of Khindivi study

2026-07-29T11:20:53.000Z - 6 weeks ago

Eton reports results from new formulation of Khindivi study


Eton Pharmaceuticals initiated with a Buy at Canaccord

2026-07-17T09:40:14.000Z - 1 month ago

Eton Pharmaceuticals initiated with a Buy at Canaccord


Eton Pharmaceuticals initiated with a Buy at Canaccord

2026-07-16T20:16:10.000Z - 1 month ago

Eton Pharmaceuticals initiated with a Buy at Canaccord


Eton Pharmaceuticals Earnings Call Transcript: Q1 2026

May 14, 2026, 4:30 PM EDT - 4 months ago

Eton Pharmaceuticals Earnings Call Transcript: Q1 2026


Eton Pharmaceuticals Earnings release: Q1 2026

May 14, 2026, 4:30 PM EDT - 4 months ago

Eton Pharmaceuticals Earnings release: Q1 2026


Eton Pharmaceuticals Quarterly report: Q1 2026

May 14, 2026, 4:30 PM EDT - 4 months ago

Eton Pharmaceuticals Quarterly report: Q1 2026


Eton Pharmaceuticals announces relaunch of Hemangeol

2026-05-01T11:06:48.000Z - 4 months ago

Eton Pharmaceuticals announces relaunch of Hemangeol


Eton Pharmaceuticals Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Eton Pharmaceuticals Proxy statement: Proxy filing


Eton Pharmaceuticals appoints Judith Matthews as CFO

2026-04-16T11:31:33.000Z - 4 months ago

Eton Pharmaceuticals appoints Judith Matthews as CFO


Eton Pharmaceuticals Announces CFO Succession Plan

Apr 16, 2026, 6:50 AM EDT - 4 months ago

Eton Pharmaceuticals Announces CFO Succession Plan


Eton Pharmaceuticals Earnings Call Transcript: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 5 months ago

Eton Pharmaceuticals Earnings Call Transcript: Q4 2025


Eton Pharmaceuticals Annual report: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 5 months ago

Eton Pharmaceuticals Annual report: Q4 2025


Eton Pharmaceuticals Earnings release: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 5 months ago

Eton Pharmaceuticals Earnings release: Q4 2025


US FDA approves Eton Pharma's hormonal disorder drug

Feb 25, 2026, 1:51 PM EST - 6 months ago

US FDA approves Eton Pharma's hormonal disorder drug


Eton Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Eton Pharmaceuticals Earnings Call Transcript: Q3 2025


Eton Pharmaceuticals Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Eton Pharmaceuticals Quarterly report: Q3 2025


Eton Pharmaceuticals Earnings release: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Eton Pharmaceuticals Earnings release: Q3 2025


Eton Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Eton Pharmaceuticals Earnings Call Transcript: Q2 2025


Eton Pharmaceuticals Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Eton Pharmaceuticals Quarterly report: Q2 2025


Eton Pharmaceuticals Earnings release: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Eton Pharmaceuticals Earnings release: Q2 2025


Eton Pharmaceuticals Slides: Corporate Presentation

May 19, 2025, 7:00 AM EDT - 1 year ago

Eton Pharmaceuticals Slides: Corporate Presentation


Eton Pharmaceuticals Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Eton Pharmaceuticals Earnings Call Transcript: Q1 2025


Eton Pharmaceuticals Quarterly report: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Eton Pharmaceuticals Quarterly report: Q1 2025


Eton Pharmaceuticals Earnings release: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Eton Pharmaceuticals Earnings release: Q1 2025


Eton Pharmaceuticals Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Eton Pharmaceuticals Proxy statement: Proxy Filing


Eton Pharmaceuticals Slides: Investor Presentation

Apr 4, 2025, 7:00 AM EDT - 1 year ago

Eton Pharmaceuticals Slides: Investor Presentation


Eton Pharmaceuticals Transcript: Investor Day 2025

Mar 18, 2025, 10:00 AM EDT - 1 year ago

Eton Pharmaceuticals Transcript: Investor Day 2025


Eton Pharmaceuticals Earnings release: Q4 2024

Mar 18, 2025, 10:00 AM EDT - 1 year ago

Eton Pharmaceuticals Earnings release: Q4 2024


Eton Pharmaceuticals Annual report: Q4 2024

Mar 18, 2025, 10:00 AM EDT - 1 year ago

Eton Pharmaceuticals Annual report: Q4 2024


Eton Pharmaceuticals Slides: FY 2025

Mar 18, 2025, 10:00 AM EDT - 1 year ago

Eton Pharmaceuticals Slides: FY 2025


Eton Pharmaceuticals Earnings Call Transcript: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Eton Pharmaceuticals Earnings Call Transcript: Q3 2024


Eton Pharmaceuticals Quarterly report: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Eton Pharmaceuticals Quarterly report: Q3 2024


Eton Pharmaceuticals Earnings release: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Eton Pharmaceuticals Earnings release: Q3 2024


AllenNash21
AllenNash21 Sep. 11 at 4:29 AM
$ETON personal price target of $75 by year end
0 · Reply
Dusan8989
Dusan8989 Sep. 9 at 2:55 PM
$ETON beast on red day
1 · Reply
badgermobile
badgermobile Sep. 9 at 1:10 AM
$ETON they just keep delivering with rev growth and margins acceleration. I think they will hit $100 early next year with continued success
0 · Reply
AllenNash21
AllenNash21 Sep. 8 at 9:56 PM
$ETON serves as a model for other Bios to emulate.
0 · Reply
SpyVsSpy2
SpyVsSpy2 Sep. 2 at 7:42 PM
0 · Reply
kshonstocks
kshonstocks Sep. 2 at 1:38 PM
$ETON back over 9 dma
1 · Reply
Merlintrader
Merlintrader Sep. 2 at 12:44 AM
Eton Pharmaceuticals ($ETON) Stock Hub 2026: Q2 growth, 145M guidance and the valuation test Free Biotech Catalyst Calendar on Merlintrader. https://www.merlintrader.com/eton-pharmaceuticals-stock-hub/
0 · Reply
parcha
parcha Aug. 27 at 12:26 AM
$ETON Eton Pharmaceuticals : “It’s a biotech that’s been a winner. I like to take a little bit off of the biotech winner and then let the rest run.” https://www.cnbc.com/2026/08/26/cramers-lightning-round-buy-qxo.html
0 · Reply
oaksapollo
oaksapollo Aug. 26 at 4:28 PM
$ETON It's interesting, if you look at the bids on calls in Oct, Nov, they're pretty insane. For example, the bid on a November $90 call is $0.90. Pretty bullish, but there is no volume.
0 · Reply
CARTE_BLANCHE_DEVEREAUX
CARTE_BLANCHE_DEVEREAUX Aug. 26 at 4:11 PM
$ETON $SLS $PYPD Closed half my position here. Moved gains from here to $DRTS
3 · Reply
STACKD0E
STACKD0E Aug. 25 at 5:23 PM
$ETON 🙃✨️
0 · Reply
kshonstocks
kshonstocks Aug. 25 at 4:59 PM
$CDNA and $ETON #1 and #2 https://research.investors.com/stock-lists/relative-strength-at-new-high/
0 · Reply
Dusan8989
Dusan8989 Aug. 25 at 2:06 PM
$ETON this one is recovering very fast
0 · Reply
jgallerick
jgallerick Aug. 25 at 12:16 PM
0 · Reply
findingthestock
findingthestock Aug. 25 at 1:21 AM
$ACHV $ARDX $ETON $IOVA $SENS @aljudaia92 I see nothing wrong with how you traded You took profits or minimized losses Had those stocks had a negative outcome the stock price would have dropped a lot Many invested in Ardelyx have chased and have high averages those who got in 8,9s etc or even higher Many have been with Ardelyx for many years Even if a buyout based on their high averages and amount of time they have been invested it would not be a great return compared to the opportunity cost if traded another for same amount of time
2 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Aug. 24 at 10:49 PM
$ETON no stopping this now
0 · Reply
aljudaia92
aljudaia92 Aug. 24 at 6:53 PM
$ARDX Those who refuse to learn from the past rarely succeed in the future. I’ve taken my share of painful lessons and missed great opportunities because of fear. I sold $ACHV at $4 because I was worried about a CRL—then watched it surge 120%. I sold $IOVA at $1.80 after being scared off by the complexity of its treatment, along with a miserable Goldman Sachs report predicting the stock could fall to $1—then it climbed above $9. I sold $ETON at $24 because I was concerned about the new CEO and all the talk blaming her for the failure of her previous company—then ETON went on to reach $64. But I learned. I bought $SENS, ignored the endless negativity, stayed patient, and didn’t sell until I had made a 100% profit. Today, I’m doing it again. I’m buying a great company going through temporary difficulties—problems I believe it can overcome. And if the thesis plays out, I believe a 50% return in less than three months is entirely possible. There are no failures—only lessons
Dusan8989
Dusan8989 Aug. 24 at 1:03 PM
$ETON just woow
0 · Reply
BeverlyAnderson803
BeverlyAnderson803 Aug. 22 at 3:40 PM
$KOLD $ETON $EL $BETA $SUI KOLD provides leveraged inverse natural-gas exposure, Eton advances treatments for rare diseases, Estee Lauder remains focused on beauty and consumer demand, BETA remains speculative, and Sui benefits from blockchain adoption and network activity. I'm watching natural-gas prices, clinical milestones, consumer spending, and crypto activity.
0 · Reply
kshonstocks
kshonstocks Aug. 22 at 12:40 PM
$ETON back up on higher volume, love the way this one is acting
0 · Reply
bryantboy99
bryantboy99 Aug. 22 at 3:01 AM
$ETON not selling any till $100
0 · Reply